Europe Pharmaceutical Drug Delivery Market to Grow with a CAGR of 6.36% through 2028
Growing geriatric population in Europe and development
of nanotechnology-based delivery systems is expected to drive the Europe Pharmaceutical
Drug Delivery Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Europe Pharmaceutical
Drug Delivery Market – Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the Europe Pharmaceutical Drug Delivery Market
stood at USD 464.65 million in 2022 and is anticipated to grow with a CAGR of 6.36%
in the forecast period, 2024-2028. The rising prevalence of chronic diseases
such as diabetes, cancer, and respiratory conditions necessitates advanced drug
delivery systems. The surge in biologics in the pharmaceutical markets promotes
the use of innovative drug delivery technologies.
Furthermore, technological advancements and the
development of new drugs also contribute significantly to market growth.
Strategic expansions through mergers and acquisitions by key players in this
region play a vital role in propelling the market's expansion.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Europe Pharmaceutical Drug Delivery Market”
The European Pharmaceutical Drug Delivery Market is
showing promising growth and expansion due to various factors. The region is
known for its strong healthcare infrastructure and emphasis on research and
innovation, which is driving the drug delivery market in a significant way.
Primary factors leading this growth include the
surging prevalence of chronic conditions, such as cardiovascular diseases,
diabetes, and cancer. These conditions require innovative drug delivery systems
for effective treatment, fueling the demand within the market. Additionally,
the aging population in Europe is also contributing to the expansion of the
pharmaceutical drug delivery market. As the elderly are more prone to chronic
diseases, the need for effective drug delivery systems is escalating.
Technological advancements are reshaping the market,
pushing for more efficient, reliable, and precise drug delivery systems.
Innovations in nanotechnology, for instance, are leading to the development of
nanocarriers, which can deliver drugs directly to the diseased cells, thereby
improving the effectiveness of the drug and reducing side effects. Similarly,
the advent of 3D printing technology is creating opportunities for personalized
drug delivery systems, providing medicines tailored to individual patient
needs. Moreover, the collaboration between pharmaceutical companies and drug
delivery technology firms is also a significant trend in the European market.
These partnerships aim to combine pharmaceutical expertise with novel drug
delivery technologies to develop advanced therapeutics that can enhance patient
outcomes.
Regulatory support from the European Union (EU) also
aids the market growth. The EU's robust regulations ensure the safety and
efficacy of drug delivery systems, fostering trust and acceptance among
healthcare professionals and patients. Furthermore, the EU provides funding for
research and development activities in the healthcare sector, encouraging the
exploration and adoption of innovative drug delivery systems.
In recent years, there have been several commonly
known infectious diseases occurring in France, including yellow fever, dengue
fever, Rift valley fever, and Zika virus infections. These diseases have posed
significant challenges to public health and have necessitated proactive
measures to prevent their spread. For example, in August 2018, the French
National Reference Centre for Arboviruses, located at the Institut Pasteur de
la Guyane, reported an autochthonous (locally acquired) laboratory-confirmed
case of yellow fever. This case involved an unvaccinated 47-year-old Swiss man
who contracted the disease in French Guiana. This incident highlighted the
importance of vaccination and raised awareness about the risks associated with
these infectious diseases. It is worth noting that Spain was one of the
earliest countries to identify and address the yellow fever epidemic. However,
historians believe that this recognition may have been influenced by wartime
censorship. Nevertheless, the emergence of yellow fever in Spain underscores
the global nature of these infectious diseases and the need for international
cooperation in their prevention and control.
Given the increasing prevalence of infectious
diseases, it is anticipated that there will be a growing demand for
pharmaceutical drug delivery systems in the region in the coming years. These
systems play a crucial role in ensuring the timely and efficient distribution
of medications, vaccines, and other medical supplies to combat the spread of
infectious diseases and safeguard public health.
The Europe Pharmaceutical Drug Delivery Market is
segmented into formulation, route of administration, application, end user,
country distribution, and company.
Based on end user, hospitals are currently dominating
the Europe Pharmaceutical Drug Delivery Market based on end user, and this can
be attributed to several factors. Firstly, the hospital setting itself plays a
crucial role, as it is where a significant number of procedures requiring drug
administration take place. With a wide range of drug delivery devices and
sophisticated equipment at their disposal, hospitals are able to ensure
precise, controlled, and efficient drug delivery to patients.
Furthermore, the prevalence of chronic diseases that
necessitate hospitalization has contributed to the dominance of hospitals in
this market. These health institutions have recognized the importance of
effective and timely drug delivery, which has led to the development of
specialized protocols and dedicated resources for this purpose. As a result,
hospitals have become the go-to choice for patients in need of pharmaceutical
drug delivery. It is also worth noting that the continuous expansion of
healthcare infrastructure and the increasing investment in hospital facilities
across Europe have further propelled the growth of this sector in the
pharmaceutical drug delivery market. With state-of-the-art facilities and a focus
on delivering high-quality healthcare services, hospitals have solidified their
position as key players in this industry. Hospitals' dominance in the Europe
Pharmaceutical Drug Delivery Market is a result of their inherent advantages,
such as the availability of advanced drug delivery devices, the prevalence of
chronic diseases, and the continuous investment in healthcare infrastructure.
These factors have positioned hospitals as leaders in ensuring efficient and
effective drug delivery to patients across Europe.
Based on country, Germany's leadership in the European
Pharmaceutical Drug Delivery Market is attributed to several key factors.
Firstly, the nation boasts a robust healthcare infrastructure that provides a
solid foundation for innovation. With substantial investments in research and
development, Germany remains at the forefront of drug delivery technology
advancements, consistently pushing the boundaries of what is achievable. Additionally,
the presence of major pharmaceutical companies within Germany further
reinforces its dominance in the market. These companies leverage the country's
favorable business environment and benefit from its efficient yet stringent
regulatory framework, ensuring strict adherence to product quality and safety
standards.
Moreover, Germany's strategic location in Europe plays
a pivotal role in its success. Its central position enables seamless export of
pharmaceutical products to other European countries, strengthening its market
presence and expanding its reach. Germany's prominent position in the European
Pharmaceutical Drug Delivery Market is the result of its robust healthcare
infrastructure, significant investments in research and development, strong
presence of major pharmaceutical companies, efficient regulatory framework, and
strategic location within Europe. This amalgamation of factors positions
Germany as a key player in the market, driving innovation and ensuring the
delivery of high-quality healthcare solutions for patients across Europe.
Major companies operating in Europe Pharmaceutical
Drug Delivery Market are:
- Bayer AG
- GlaxoSmithKline plc,
- MERCK KGaA
- Pfizer Inc.
- Novartis AG
- Sanofi S.A.
- Johnson & Johnson
- F. Hoffmann-La Roche AG
- 3M Company
- Becton, Dickinson And Company
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The increasing emphasis on personalized medicine and
targeted therapies is propelling the europe market. Furthermore, ongoing
advancements in drug formulation and delivery technologies are effectively
driving this market forward. Additionally, researchers are continuously
innovating with approaches such as nanotechnology, liposomes, and
microparticles to enhance drug stability, bioavailability, and controlled
release. These innovations enable the development of novel drug delivery
systems that address challenges associated with traditional formulations, such
as poor solubility, rapid metabolism, or short half-life. Consequently, the
market is experiencing significant growth. Moreover, the rising prevalence of
chronic diseases, including diabetes, cardiovascular disorders, and cancer, is
fueling the demand for advanced drug delivery systems. These conditions often
require long-term treatment with multiple medications, and optimized drug delivery
methods can greatly improve therapeutic outcomes and patients' quality of life.
Other factors, such as rapid urbanization, continuous improvements in the
healthcare sector, and extensive research and development (R&D) activities
conducted by key players, are also exerting a positive influence on the market.,”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Europe Pharmaceutical
Drug Delivery Market By Formulation (Conventional Drug Delivery, Novel Drug
Delivery), By Route of Administration (Oral, Injectable, Topical, Ocular,
Pulmonary, Nasal, Transmucosal, Implantable), By Application (Infectious
Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases,
Central Nervous System Disorders, Autoimmune Diseases, Others), By End User
(Hospitals, Home Care Settings, ASC/Clinics, Others), By Country, Forecast
& Opportunities, 2018-2018F”, has evaluated
the future growth potential of Europe Pharmaceutical Drug Delivery Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Europe Pharmaceutical Drug Delivery Market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]
Website:
www.techsciresearch.com